Morgan Stanley upgraded Cemex (CX) to Overweight from Equal Weight with an unchanged $14 price target The company is ahead of the curve on margin protection, entering this period from a materially stronger starting point than in 2022, the analyst tells investors in a research note. Cemex’s stronger balance sheet, also skews risk-reward on the stock decisively to the upside, the firm added.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CX:
- Cemex to Divest Colombian Assets in US$555 Million Portfolio Rebalancing Move
- Cemex to divest certain operations in Colombia for $555M
- Cemex upgraded to Outperform from Market Perform at Itau BBA
- Scotiabank upgrades Cemex to Outperform on recent selloff
- Cemex Confirms March Dividend Installment Payment From Tax-Free Profit Account